Medidata and Median Technologies announced a new collaboration to streamline the growth and use of medical imaging in cancer clinical trials. Median Technologies will leverage the Medidata Clinical Cloud to accelerate the development of medicines in oncology with new, scalable image management services.
Median Technologies will leverage Medidata Medical Imaging to transition its legacy imaging study management systems to a single digital environment, gaining access to configurable image workflows, while still maintaining global regulatory standards.
“Our collaboration with Medidata will not only ease the management of images during clinical drug trials, it will enhance our analytical rigor, enabling our teams to extract high-quality imaging biomarkers for better study and patient outcomes,” said Jeanne Hecht, Median Technologies’ Chief Operating Officer. “Medidata’s imaging technology provides us with complementary capabilities to fulfill the unique R&D needs of our growing customer-base in Europe, Asia and the US. We’re dedicated to helping biopharmaceutical companies make more informed decisions to quickly bring new cancer therapies to market, and are thrilled to partner with Medidata to aid in those efforts.”
Medidata Medical Imaging provides workflow management and flexibility of image resources, working with proprietary technologies like Median. The collaboration will provide Median with the control and access to image data and performance metrics, while enabling automatic edit checks and de-identification.